Summit Therapeutics Inc.
SMMT
$17.61
-$1.30-6.88%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 121.40% | 144.74% | 51.37% | -35.24% | -46.58% |
| Total Receivables | -34.32% | -18.72% | -79.31% | -79.00% | -86.13% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 301.18% | -52.50% | -66.32% | 348.82% | 74.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 169.17% | -82.09% | -22.49% | -- |
| Total Current Assets | 123.36% | 139.22% | 44.52% | -34.17% | -71.11% |
|
|
|||||
| Total Current Assets | 123.36% | 139.22% | 44.52% | -34.17% | -71.11% |
| Net Property, Plant & Equipment | 22.02% | 24.26% | 23.79% | 120.14% | 19.33% |
| Long-term Investments | -1.53% | 9.76% | -0.16% | 1.96% | 5.28% |
| Goodwill | -1.53% | 9.76% | -0.16% | 1.96% | 5.28% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -51.75% | -54.12% | 192.44% | 202.03% | 815.25% |
| Total Assets | 114.62% | 130.16% | 44.02% | -30.65% | -69.44% |
|
|
|||||
| Total Accounts Payable | 73.83% | -1.87% | 238.40% | 797.32% | 651.27% |
| Total Accrued Expenses | 121.86% | 269.04% | 337.12% | -14.54% | -12.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 34.03% | -72.47% | 3,441.26% | 118.49% | -86.91% |
| Total Finance Division Other Current Liabilities | 150.63% | 112.19% | 30.21% | 146.25% | 8.31% |
| Total Other Current Liabilities | 150.63% | 112.19% | 30.21% | 146.25% | 8.31% |
| Total Current Liabilities | 104.50% | -48.12% | 1,074.82% | 34.37% | -47.39% |
|
|
|||||
| Total Current Liabilities | 104.50% | -48.12% | 1,074.82% | 34.37% | -47.39% |
| Long-Term Debt | -- | -- | -- | 0.00% | -79.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.95% | 8.46% | 15.84% | 133.76% | 19.07% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.35% | 16.26% | 5.63% | 123.50% | 9.31% |
| Total Liabilities | -62.63% | -45.48% | 24.63% | 9.19% | -76.70% |
|
|
|||||
| Common Stock & APIC | 49.58% | 50.57% | 22.43% | 2.63% | 111.77% |
| Retained Earnings | -22.28% | -20.56% | -17.29% | -12.60% | -162.54% |
| Treasury Stock & Other | 6.66% | 0.65% | -2.54% | -75.43% | -29.32% |
| Total Common Equity | 400.37% | 340.66% | 63.11% | -66.88% | -38.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 400.37% | 340.66% | 63.11% | -66.88% | -38.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 400.37% | 340.66% | 63.11% | -66.88% | -38.66% |
|
|
|||||
